Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Whistleblower Lawsuit Accuses Par of Illegal Drug-Switching Scheme
Go back to Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Whistleblower Lawsuit Accuses Par of Illegal Drug-Switching Scheme| Mylan Inc. (NASDAQ: MYL) | Delayed: 15.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.86 | 52 Week High | $55.51 | |||
| Open | $10.56 | 52 Week Low | $33.60 | |||
| Day High | $15.86 | P/E | 10.43 | |||
| Day Low | $15.86 | EPS | $1.52 | |||
| Volume | 45,581 | |||||
| Par Pharmaceutical Cos., Inc. (NYSE: PRX) | Delayed: 49.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.98 | 52 Week High | $52.33 | |||
| Open | $0.02 | 52 Week Low | $26.57 | |||
| Day High | $49.98 | P/E | 24.26 | |||
| Day Low | $49.98 | EPS | $2.06 | |||
| Volume | 7,000 | |||||
